| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | Q3PJ4B4D0X |
| InChI Key | BGOQGUHWXBGXJW-RHSMWYFYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H17NO2 |
| Molecular Weight | 267.33 |
| AlogP | 2.65 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 52.49 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 20.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Lyase
|
2-141 | - | - | - | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Adrenergic receptor
|
- | - | - | 1200 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
7-19 | 6-149 | 2300-13000 | 58-2607 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | - | - | 2400 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cocaine-Related Disorders | 1 | D019970 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 123039-93-0 |
| ChEBI | 124993 |
| ChEMBL | CHEMBL25856 |
| DrugBank | DB16139 |
| FDA SRS | Q3PJ4B4D0X |
| Guide to Pharmacology | 9267 |
| PubChem | 5311070 |
| SureChEMBL | SCHEMBL4614575 |
| ZINC | ZINC000025758512 |